1621P First-line pembrolizumab alone or with investigational agents for advanced melanoma: Updated results from the phase I/II KEYMAKER-U02 substudy 02B.
Saved in:
| Title: | 1621P First-line pembrolizumab alone or with investigational agents for advanced melanoma: Updated results from the phase I/II KEYMAKER-U02 substudy 02B. |
|---|---|
| Authors: | Gogas, H.1 (AUTHOR), Dummer, R.2 (AUTHOR), Shapira-Frommer, R.3 (AUTHOR), Pigozzo, J.4 (AUTHOR), Ascierto, P.A.5 (AUTHOR), Gaudy Marqueste, C.6 (AUTHOR), Portnoy, D.7 (AUTHOR), Del Vecchio, M.8 (AUTHOR), Bar-Sela, G.9 (AUTHOR), Cohen, J.10 (AUTHOR), Di Giacomo, A.M.11 (AUTHOR), Ribas, A.12 (AUTHOR), Dutriaux, C.13 (AUTHOR), Belli, C.14 (AUTHOR), Cohen, G.L.15 (AUTHOR), Dokhan, R.16 (AUTHOR), Jing, N.17 (AUTHOR), Lal, R.18 (AUTHOR), Long, G.V.19 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS962-S963. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189420039 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1621P First-line pembrolizumab alone or with investigational agents for advanced melanoma: Updated results from the phase I/II KEYMAKER-U02 substudy 02B. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gogas%2C+H%2E%22">Gogas, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dummer%2C+R%2E%22">Dummer, R.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shapira-Frommer%2C+R%2E%22">Shapira-Frommer, R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pigozzo%2C+J%2E%22">Pigozzo, J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ascierto%2C+P%2EA%2E%22">Ascierto, P.A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gaudy+Marqueste%2C+C%2E%22">Gaudy Marqueste, C.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Portnoy%2C+D%2E%22">Portnoy, D.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Del+Vecchio%2C+M%2E%22">Del Vecchio, M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bar-Sela%2C+G%2E%22">Bar-Sela, G.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cohen%2C+J%2E%22">Cohen, J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Di+Giacomo%2C+A%2EM%2E%22">Di Giacomo, A.M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ribas%2C+A%2E%22">Ribas, A.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dutriaux%2C+C%2E%22">Dutriaux, C.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Belli%2C+C%2E%22">Belli, C.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cohen%2C+G%2EL%2E%22">Cohen, G.L.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dokhan%2C+R%2E%22">Dokhan, R.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jing%2C+N%2E%22">Jing, N.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lal%2C+R%2E%22">Lal, R.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Long%2C+G%2EV%2E%22">Long, G.V.</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS962-S963. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189420039 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.2249 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S962 Titles: – TitleFull: 1621P First-line pembrolizumab alone or with investigational agents for advanced melanoma: Updated results from the phase I/II KEYMAKER-U02 substudy 02B. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gogas, H. – PersonEntity: Name: NameFull: Dummer, R. – PersonEntity: Name: NameFull: Shapira-Frommer, R. – PersonEntity: Name: NameFull: Pigozzo, J. – PersonEntity: Name: NameFull: Ascierto, P.A. – PersonEntity: Name: NameFull: Gaudy Marqueste, C. – PersonEntity: Name: NameFull: Portnoy, D. – PersonEntity: Name: NameFull: Del Vecchio, M. – PersonEntity: Name: NameFull: Bar-Sela, G. – PersonEntity: Name: NameFull: Cohen, J. – PersonEntity: Name: NameFull: Di Giacomo, A.M. – PersonEntity: Name: NameFull: Ribas, A. – PersonEntity: Name: NameFull: Dutriaux, C. – PersonEntity: Name: NameFull: Belli, C. – PersonEntity: Name: NameFull: Cohen, G.L. – PersonEntity: Name: NameFull: Dokhan, R. – PersonEntity: Name: NameFull: Jing, N. – PersonEntity: Name: NameFull: Lal, R. – PersonEntity: Name: NameFull: Long, G.V. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
